high blood pressure and tirzepatide How Helps Lower & Manage Hypertension Mounjaro, Zepbound weight loss drugs

Eli Lilly Chief Corporate Brand Officer Lina Polimeni on how the brand differentiates itself in the crowded pharma market, including with its GLP-1 medications.

This practice recommendation serves as an update to the 2023 AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty...

A video from Colton Jones (as part of Insights from 2026 ASCO GI Annual Meeting), posted on Jan 20, 2026.

However, its future trajectory is far from linear as many uncertainties remain, e.g., acceptance of obesity as a chronic disease, budget impact faced by payers and health systems willingness and ability to pay, the readout of further cardiovascular outcomes trials after the high profile results of 2023s SELECT trial for Wegovy, or new entrants challenging first generation therapies with alternative mechanisms of action (MoA) to address shortcomings such as gastrointestinal tolerability, current drugs being injectables, or the durability and quality of weight loss which distinguishes between fat and lean body mass

This 15mg KwikPen dose continues a structured weight-management plan and is supplied for one full month, subject to prescriber review at AYP Healthcare.